PH19211A - N-(1-allyl-2-pyrrolidinylmethyl)-2-methoxy-4-amino-5-methylsulphamoyl benzamide derivatives and pharmaceutical compositions - Google Patents

N-(1-allyl-2-pyrrolidinylmethyl)-2-methoxy-4-amino-5-methylsulphamoyl benzamide derivatives and pharmaceutical compositions

Info

Publication number
PH19211A
PH19211A PH197873A PH1978A PH19211A PH 19211 A PH19211 A PH 19211A PH 197873 A PH197873 A PH 197873A PH 1978 A PH1978 A PH 1978A PH 19211 A PH19211 A PH 19211A
Authority
PH
Philippines
Prior art keywords
pyrrolidinylmethyl
allyl
methoxy
amino
pharmaceutical compositions
Prior art date
Application number
PH197873A
Other languages
English (en)
Inventor
J Perrot
M Thominet
Original Assignee
Ile De France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ile De France filed Critical Ile De France
Publication of PH19211A publication Critical patent/PH19211A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Hydrogenated Pyridines (AREA)
PH197873A 1980-08-28 1981-07-28 N-(1-allyl-2-pyrrolidinylmethyl)-2-methoxy-4-amino-5-methylsulphamoyl benzamide derivatives and pharmaceutical compositions PH19211A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8018635A FR2489327B1 (fr) 1980-08-28 1980-08-28 N (1 allyl 2 pyrrolidinyl methyl) 2 methoxy 4 amino 5 methylsulfa moyl benzamide, son procede de preparation et son application comme medicament

Publications (1)

Publication Number Publication Date
PH19211A true PH19211A (en) 1986-02-04

Family

ID=9245444

Family Applications (1)

Application Number Title Priority Date Filing Date
PH197873A PH19211A (en) 1980-08-28 1981-07-28 N-(1-allyl-2-pyrrolidinylmethyl)-2-methoxy-4-amino-5-methylsulphamoyl benzamide derivatives and pharmaceutical compositions

Country Status (41)

Country Link
US (2) US4405636A (es)
EP (1) EP0047207B1 (es)
JP (1) JPS5775969A (es)
KR (1) KR840002063B1 (es)
AR (1) AR226737A1 (es)
AT (1) ATE11911T1 (es)
AU (1) AU549396B2 (es)
BE (1) BE890085A (es)
BG (1) BG36931A3 (es)
CA (1) CA1168250A (es)
CH (1) CH648299A5 (es)
CS (1) CS223895B2 (es)
DD (1) DD202011A5 (es)
DE (2) DE3133768A1 (es)
DK (1) DK157845C (es)
EG (1) EG15376A (es)
ES (1) ES8301466A1 (es)
FI (1) FI73207C (es)
FR (1) FR2489327B1 (es)
GB (1) GB2083033B (es)
GR (1) GR74560B (es)
HK (1) HK55989A (es)
HU (1) HU183555B (es)
IE (1) IE51357B1 (es)
IL (1) IL63217A (es)
IN (1) IN155495B (es)
IS (1) IS1213B6 (es)
IT (1) IT1171490B (es)
JO (1) JO1120B1 (es)
LU (1) LU83583A1 (es)
MA (1) MA19218A1 (es)
MX (1) MX6707E (es)
NO (1) NO155097C (es)
OA (1) OA06877A (es)
PH (1) PH19211A (es)
PL (1) PL135397B1 (es)
PT (1) PT73509B (es)
SU (1) SU1148559A3 (es)
YU (1) YU42581B (es)
ZA (1) ZA814575B (es)
ZW (1) ZW17581A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8317597D0 (en) * 1983-06-29 1983-08-03 Beecham Group Plc Pharmaceutical compounds
FR2550447B1 (fr) * 1983-08-10 1986-01-17 Ile De France Application du n-(ally-2-pyrrolidinylmethyl) 2-methoxy 4-amino 5-methylsulfamoyl benzamide comme antiagregant plaquettaire
FR2584605B1 (fr) * 1985-07-15 1988-06-17 Ile De France Application du n-(1-allyl-2-pyrrolidinylmethyl) 2-methoxy 4-amino 5-methylsulfamoyl benzamide dans le traitement de la maladie de parkinson
US7544676B2 (en) * 2005-11-10 2009-06-09 Adolor Corporation Sulfamoyl benzamides and methods of their use
CN101628886B (zh) * 2009-08-25 2012-12-12 北京紫萌同达科技有限公司 一种2-甲氧基-4-氨基-5-乙砜基苯甲酸的合成方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1525M (fr) * 1961-07-25 1962-11-16 Ile De France Médicaments antiémétiques nouveaux.
US3342826A (en) * 1964-01-13 1967-09-19 Ile De France Heterocyclic aminoalkyl benzamides
FR5916M (es) * 1966-01-21 1968-05-06
US3766178A (en) * 1967-04-03 1973-10-16 Ile De France Substituted 2-arylalkyloxy benzamides
GB1364231A (en) 1968-12-23 1974-08-21 Robins Co Inc A H N-/1-substituted-3-pyrrolidinyl/benzamides and thiobenzamides
US3862139A (en) * 1972-06-23 1975-01-21 Delmar Chem Heterocyclic benzamide compounds
FR2244760B1 (es) * 1973-09-25 1980-06-27 Ile De France
CH605793A5 (es) * 1974-03-05 1978-10-13 Ile De France
FR2294698A1 (fr) * 1974-12-18 1976-07-16 Synthelabo Nouveaux derives des methoxy-2 benzamides substitues, leurs sels, leur preparation et les medicaments qui en renferment
US4197243A (en) * 1975-04-02 1980-04-08 Yamanouchi Pharmaceutical Co., Ltd. N-1-Benzyl-3-pyrrolidinyl-4-dimethylamino benzamide derivatives
US4186135A (en) * 1976-08-04 1980-01-29 Societe D'etudes Scientifiques Et Industrielles De L'ile-De-France Substituted 2,3-alkylene bis (oxy) benzamides and derivatives and method of preparation
FR2438650A1 (fr) * 1978-10-11 1980-05-09 Ile De France N-(1-methyl 2-pyrrolidinyl methyl) 2,3-dimethoxy 5-methylsulfamoyl benzamide et ses derives, leurs methodes de preparation et leur application dans le traitement des troubles du bas appareil urinaire
US4210660A (en) * 1978-12-20 1980-07-01 Yamanouchi Pharmaceutical Co., Ltd. Benzamide derivatives
JPS55130957A (en) * 1979-03-30 1980-10-11 Kyowa Hakko Kogyo Co Ltd Production of benzamide derivative

Also Published As

Publication number Publication date
GR74560B (es) 1984-06-29
BG36931A3 (en) 1985-02-15
AU549396B2 (en) 1986-01-23
US4550179A (en) 1985-10-29
FI73207B (fi) 1987-05-29
DK383081A (da) 1982-03-01
YU201081A (en) 1983-10-31
IE811449L (en) 1982-02-28
IL63217A (en) 1985-03-31
LU83583A1 (fr) 1981-12-01
NO155097B (no) 1986-11-03
NO155097C (no) 1987-02-11
FI73207C (fi) 1987-09-10
DK157845C (da) 1990-07-23
IS2654A7 (is) 1981-09-11
JPH0233027B2 (es) 1990-07-25
HK55989A (en) 1989-07-21
CS223895B2 (en) 1983-11-25
KR830006201A (ko) 1983-09-20
JPS5775969A (en) 1982-05-12
DE3169052D1 (en) 1985-03-28
KR840002063B1 (ko) 1984-11-09
IT8149179A0 (it) 1981-08-26
MX6707E (es) 1985-10-23
ES503805A0 (es) 1982-12-01
SU1148559A3 (ru) 1985-03-30
AR226737A1 (es) 1982-08-13
OA06877A (fr) 1983-04-30
PT73509A (fr) 1981-09-01
EP0047207A1 (fr) 1982-03-10
GB2083033A (en) 1982-03-17
IT1171490B (it) 1987-06-10
PT73509B (fr) 1982-10-28
US4405636A (en) 1983-09-20
PL232686A1 (es) 1982-03-01
EG15376A (en) 1986-12-30
EP0047207B1 (fr) 1985-02-20
DK157845B (da) 1990-02-26
FR2489327A1 (fr) 1982-03-05
FR2489327B1 (fr) 1984-05-18
ES8301466A1 (es) 1982-12-01
NO812937L (no) 1982-03-01
CA1168250A (fr) 1984-05-29
PL135397B1 (en) 1985-10-31
ZW17581A1 (en) 1981-10-21
IS1213B6 (is) 1986-04-02
HU183555B (en) 1984-05-28
IE51357B1 (en) 1986-12-10
FI812506L (fi) 1982-03-01
YU42581B (en) 1988-10-31
DD202011A5 (de) 1983-08-24
IN155495B (es) 1985-02-09
ZA814575B (en) 1982-07-28
CH648299A5 (fr) 1985-03-15
BE890085A (fr) 1982-02-26
JO1120B1 (en) 1982-07-10
AU7464281A (en) 1982-03-04
GB2083033B (en) 1984-02-01
DE3133768A1 (de) 1982-06-16
ATE11911T1 (de) 1985-03-15
MA19218A1 (fr) 1982-04-01
IL63217A0 (en) 1981-10-30

Similar Documents

Publication Publication Date Title
NZ189253A (en) Amine derivatives and pharmaceutical compositions
NZ215850A (en) Heterocyclic amides and pharmaceutical compositions thereof
PH24049A (en) Substituted benzamide derivatives and pharmaceutical compositions containing the same
NZ209759A (en) Pyrrolidinone derivatives and pharmaceutical compositions thereof
NZ193798A (en) 3-thiovinyl-cephalosporin derivatives and pharmaceutical compositions
NZ212499A (en) Substituted benzamide derivatives and pharmaceutical compositions
NZ209064A (en) N 6 -diarylalkyl-adenosine derivatives and pharmaceutical compositions
NZ210105A (en) Oxazolidine derivatives and pharmaceutical compositions
NZ209952A (en) Amine derivatives and pharmaceutical compositions
PH20168A (en) 7-carboxymethoxyphenylacetamino-3-cephem derivatives and their pharmaceutical compositions
DE2964696D1 (en) N-(benzothienopyrazol)-amides and pharmaceutical compositions containing them
NZ184263A (en) N-(amino-alkyl-amino)-benzamides and pharmaceutical compositions
NZ218465A (en) N-(pyrrol-1-yl)-pyridinamine derivatives and pharmaceutical compositions
IL60376A0 (en) 3-methyleneazetidine derivatives and pharmaceutical compositions containing them
NZ208694A (en) Rooperol derivatives and pharmaceutical compositions
NZ212336A (en) N-substituted butyramide derivatives and pharmaceutical compositions
PH19575A (en) Cephalosporing derivatives and pharmaceutical compositions thereof
PH19211A (en) N-(1-allyl-2-pyrrolidinylmethyl)-2-methoxy-4-amino-5-methylsulphamoyl benzamide derivatives and pharmaceutical compositions
NZ214284A (en) Benzamide derivatives and pharmaceutical compositions
PH16220A (en) Pyrro-lidine derivatives and pharmaceutical compositions thereof
NZ205732A (en) Thiatriazine derivatives and pharmaceutical compositions
PH19518A (en) N-(2-methoxyethyl)-noroxymorphone and pharmaceutical compositions containing same
NZ203649A (en) 2-beta-d-ribofuranosylselenazole-4-carboxamide derivatives and pharmaceutical compositions
NZ207806A (en) Benzothienyl-cephalosporin derivatives and pharmaceutical compositions
IL61038A0 (en) 15-sulfonamidoprostaglandin derivatives and pharmaceutical compositions containing them